Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | DOI[10.1038/nbt.2488] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | > | 500000 | nM | 6345781 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED20 | = | 0.056 | mM kg-1 | 6864736 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 300 | umol/kg | 6864736 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED20 | > | 1 | mM kg-1 | 6864736 |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Ki | = | 70000 | nM | 10956186 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Ki | = | 3.98E+13 | nM | 15801837 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 152.6 | mg/dl | 17249729 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 130.5 | mg/dl | 17249729 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 114.9 | mg/dl | 17249729 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 138.1 | mg/dl | 17249729 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 106.3 | mg/dl | 17249729 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 99.5 | mg/dl | 17249729 |
NPT2 | Others | Unspecified | Activity | = | 19.9 | pg/hr | 17339113 | |
NPT2 | Others | Unspecified | Activity | = | 27.1 | pg/hr | 17339113 | |
NPT2 | Others | Unspecified | Activity | = | 19.9 | pg/microg/hr | 17583514 | |
NPT2 | Others | Unspecified | Activity | = | 19.6 | pg/microg/hr | 17583514 | |
NPT2 | Others | Unspecified | Activity | = | 26 | pg/microg/hr | 17583514 | |
NPT2 | Others | Unspecified | Activity | = | 27.1 | pg/microg/hr | 17583514 | |
NPT2 | Others | Unspecified | Activity | = | 20 | pg/hr | 17723306 | |
NPT2 | Others | Unspecified | Activity | = | 21.4 | pg/hr | 17723306 | |
NPT2 | Others | Unspecified | Activity | = | 35.2 | pg/hr | 17723306 | |
NPT2 | Others | Unspecified | Activity | = | 19.7 | pg/hr | 17723306 | |
NPT2 | Others | Unspecified | Activity | = | 20.7 | pg/hr | 17723306 | |
NPT2 | Others | Unspecified | Activity | = | 34.4 | pg/hr | 17723306 | |
NPT2217 | Individual Protein | Cytochrome P450 51 | Homo sapiens | IC50 | > | 200000 | nM | 17194716 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Kd | = | 6025.6 | nM | 18348514 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.16 | ug | 9214731 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.17 | ug | 9214731 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.495 | ug | 9214731 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.37 | ug | 9214731 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 7.8 | umol/ml | 15165145 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 6.3 | umol/ml | 15165145 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 5.9 | umol/ml | 15165145 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 5.2 | umol/ml | 15165145 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Activity | = | 104.2 | mg% | 6512531 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Activity | = | 129 | mg% | 6512531 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Activity | = | 154.3 | mg% | 6512531 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Activity | = | 125.2 | mg% | 6512531 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Activity | = | 104 | mg% | 6512531 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Activity | = | 95.1 | mg% | 6512531 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Activity | = | 44.1 | % | 6512531 |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 0.85 | % | 20022146 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 223.9 | nM | PubChem BioAssay data set |
NPT210 | Individual Protein | Thyroid stimulating hormone receptor | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 12589.3 | nM | PubChem BioAssay data set | |
NPT150 | Individual Protein | Anthrax lethal factor | Bacillus anthracis | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
NPT95 | Individual Protein | Muscarinic acetylcholine receptor M1 | Rattus norvegicus | Potency | = | 28.2 | nM | PubChem BioAssay data set |
NPT666 | Individual Protein | Solute carrier family 22 member 6 | Rattus norvegicus | Ki | = | 55500 | nM | 21571536 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 0 | % | 20869876 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 9 | % | 20869876 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 5 | % | 20869876 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 8.5 | % | 20869876 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 16944.1 | nM | PubChem BioAssay data set | |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 631 | nM | PubChem BioAssay data set | ||
NPT546 | Individual Protein | Retinoid X receptor alpha | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT752 | Individual Protein | Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus | Activity | = | 32.9 | % | 11883641 |
NPT305 | Individual Protein | Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus | Activity | = | 47.3 | % | 11883641 |
NPT666 | Individual Protein | Solute carrier family 22 member 6 | Rattus norvegicus | Ki | = | 55500 | nM | 10854830 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 1412.5 | nM | PubChem BioAssay data set | |
NPT622 | Individual Protein | Solute carrier organic anion transporter family member 2B1 | Homo sapiens | Inhibition | = | 15.5 | % | 22541068 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 5.8 | % | 22541068 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 9.1 | % | 22541068 |
NPT2 | Others | Unspecified | Activity | = | 5.45 | % | 22565215 | |
NPT2 | Others | Unspecified | Activity | = | 4.98 | % | 22565215 | |
NPT2 | Others | Unspecified | Activity | = | 2.22 | % | 22565215 | |
NPT2 | Others | Unspecified | Activity | = | 2.97 | % | 22565215 | |
NPT2 | Others | Unspecified | Activity | = | 2.76 | % | 22565215 | |
NPT2 | Others | Unspecified | Activity | = | 3.2 | nmol | 22565215 | |
NPT177 | Tissue | Aorta | Rattus norvegicus | EC50 | = | 1600 | nM | 22565215 |
NPT2 | Others | Unspecified | Inhibition | = | 6.4 | % | 22565215 | |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 125.25 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 99.86 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 33488.9 | nM | PubChem BioAssay data set | ||
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 63095.7 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 952.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 61644.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 27306 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 12.6 | nM | PubChem BioAssay data set | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 28 | % | 448683 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 47 | % | 448683 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 48 | % | 448683 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 28 | % | 15114 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 47 | % | 15114 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 48 | % | 15114 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 28 | % | 850242 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 47 | % | 850242 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 48 | % | 850242 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 41 | % | 1255659 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 43 | % | 1255659 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 29 | % | 1255659 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 16 | % | 1255659 |
NPT619 | Individual Protein | Serum albumin | Rattus norvegicus | Kd | = | 7970 | nM | 21071520 |
NPT712 | Individual Protein | Bile salt export pump | Rattus norvegicus | IC50 | > | 1000000 | nM | 21965623 |
NPT713 | Individual Protein | Bile salt export pump | Homo sapiens | IC50 | > | 1000000 | nM | 21965623 |
NPT2 | Others | Unspecified | AC50 | 290 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 8912.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 316.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 24212.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54665.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15355.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 281.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 35481.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 28183.8 | nM | PubChem BioAssay data set | ||
NPT993 | Cell Line | Hepatocyte | Mus musculus | FC | = | 1.4 | 27346791 | |
NPT993 | Cell Line | Hepatocyte | Mus musculus | FC | = | 1.8 | 27346791 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC317400 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.7473 | Intermediate Similarity | NPC35599 |
0.7473 | Intermediate Similarity | NPC302129 |
0.7236 | Intermediate Similarity | NPC32858 |
0.7236 | Intermediate Similarity | NPC194857 |
0.7115 | Intermediate Similarity | NPC471320 |
0.7115 | Intermediate Similarity | NPC471319 |
0.7019 | Intermediate Similarity | NPC108339 |
0.6774 | Remote Similarity | NPC244738 |
0.6667 | Remote Similarity | NPC14326 |
0.6667 | Remote Similarity | NPC471638 |
0.6639 | Remote Similarity | NPC476440 |
0.6634 | Remote Similarity | NPC3210 |
0.6571 | Remote Similarity | NPC245259 |
0.6526 | Remote Similarity | NPC299134 |
0.6505 | Remote Similarity | NPC473031 |
0.6476 | Remote Similarity | NPC172128 |
0.6442 | Remote Similarity | NPC12429 |
0.6421 | Remote Similarity | NPC212463 |
0.6408 | Remote Similarity | NPC203076 |
0.6396 | Remote Similarity | NPC328793 |
0.6392 | Remote Similarity | NPC139658 |
0.6389 | Remote Similarity | NPC161972 |
0.6389 | Remote Similarity | NPC303045 |
0.6383 | Remote Similarity | NPC229235 |
0.6381 | Remote Similarity | NPC470877 |
0.6354 | Remote Similarity | NPC122327 |
0.6354 | Remote Similarity | NPC112609 |
0.6354 | Remote Similarity | NPC113000 |
0.6344 | Remote Similarity | NPC181786 |
0.633 | Remote Similarity | NPC25565 |
0.6321 | Remote Similarity | NPC78041 |
0.6321 | Remote Similarity | NPC121872 |
0.6321 | Remote Similarity | NPC141139 |
0.6321 | Remote Similarity | NPC471307 |
0.6321 | Remote Similarity | NPC209764 |
0.6321 | Remote Similarity | NPC159178 |
0.6321 | Remote Similarity | NPC74936 |
0.6303 | Remote Similarity | NPC476048 |
0.63 | Remote Similarity | NPC475573 |
0.63 | Remote Similarity | NPC475289 |
0.6289 | Remote Similarity | NPC276699 |
0.6275 | Remote Similarity | NPC474088 |
0.6273 | Remote Similarity | NPC473501 |
0.6273 | Remote Similarity | NPC475439 |
0.6263 | Remote Similarity | NPC12857 |
0.6262 | Remote Similarity | NPC226438 |
0.6239 | Remote Similarity | NPC58674 |
0.623 | Remote Similarity | NPC254088 |
0.6224 | Remote Similarity | NPC271642 |
0.6211 | Remote Similarity | NPC219246 |
0.6162 | Remote Similarity | NPC98269 |
0.6162 | Remote Similarity | NPC325662 |
0.6162 | Remote Similarity | NPC290638 |
0.6147 | Remote Similarity | NPC471309 |
0.6147 | Remote Similarity | NPC7067 |
0.6139 | Remote Similarity | NPC309279 |
0.6139 | Remote Similarity | NPC192623 |
0.6134 | Remote Similarity | NPC181390 |
0.6134 | Remote Similarity | NPC475013 |
0.6132 | Remote Similarity | NPC325441 |
0.6126 | Remote Similarity | NPC33168 |
0.6126 | Remote Similarity | NPC311242 |
0.6122 | Remote Similarity | NPC98976 |
0.6121 | Remote Similarity | NPC327481 |
0.6075 | Remote Similarity | NPC315403 |
0.6055 | Remote Similarity | NPC473661 |
0.6038 | Remote Similarity | NPC53492 |
0.6038 | Remote Similarity | NPC198747 |
0.6034 | Remote Similarity | NPC143516 |
0.6019 | Remote Similarity | NPC258627 |
0.6019 | Remote Similarity | NPC316108 |
0.6 | Remote Similarity | NPC164859 |
0.6 | Remote Similarity | NPC469330 |
0.5983 | Remote Similarity | NPC474973 |
0.5983 | Remote Similarity | NPC474804 |
0.5983 | Remote Similarity | NPC130898 |
0.5981 | Remote Similarity | NPC262393 |
0.5979 | Remote Similarity | NPC121708 |
0.5979 | Remote Similarity | NPC125144 |
0.5962 | Remote Similarity | NPC119677 |
0.5955 | Remote Similarity | NPC269586 |
0.5948 | Remote Similarity | NPC88267 |
0.5948 | Remote Similarity | NPC113326 |
0.5948 | Remote Similarity | NPC224610 |
0.5948 | Remote Similarity | NPC194390 |
0.5922 | Remote Similarity | NPC231986 |
0.5913 | Remote Similarity | NPC329375 |
0.5909 | Remote Similarity | NPC265521 |
0.5905 | Remote Similarity | NPC169016 |
0.5905 | Remote Similarity | NPC133162 |
0.5895 | Remote Similarity | NPC52330 |
0.5889 | Remote Similarity | NPC120441 |
0.5889 | Remote Similarity | NPC300345 |
0.5889 | Remote Similarity | NPC65873 |
0.5889 | Remote Similarity | NPC212114 |
0.5882 | Remote Similarity | NPC473676 |
0.5877 | Remote Similarity | NPC12730 |
0.5872 | Remote Similarity | NPC78154 |
0.587 | Remote Similarity | NPC210849 |
0.587 | Remote Similarity | NPC45255 |
0.5862 | Remote Similarity | NPC474430 |
0.5862 | Remote Similarity | NPC202613 |
0.5862 | Remote Similarity | NPC471317 |
0.5856 | Remote Similarity | NPC322040 |
0.5855 | Remote Similarity | NPC208280 |
0.5847 | Remote Similarity | NPC45033 |
0.5847 | Remote Similarity | NPC471447 |
0.5843 | Remote Similarity | NPC149436 |
0.5843 | Remote Similarity | NPC277704 |
0.5833 | Remote Similarity | NPC78954 |
0.5833 | Remote Similarity | NPC239931 |
0.5833 | Remote Similarity | NPC82770 |
0.5826 | Remote Similarity | NPC469457 |
0.5824 | Remote Similarity | NPC8235 |
0.582 | Remote Similarity | NPC474584 |
0.5816 | Remote Similarity | NPC155429 |
0.5812 | Remote Similarity | NPC275467 |
0.5812 | Remote Similarity | NPC469974 |
0.5789 | Remote Similarity | NPC36440 |
0.5785 | Remote Similarity | NPC319579 |
0.5781 | Remote Similarity | NPC273830 |
0.5778 | Remote Similarity | NPC198841 |
0.5761 | Remote Similarity | NPC147062 |
0.5761 | Remote Similarity | NPC169110 |
0.5752 | Remote Similarity | NPC3371 |
0.5745 | Remote Similarity | NPC50266 |
0.5741 | Remote Similarity | NPC60408 |
0.5741 | Remote Similarity | NPC17497 |
0.5741 | Remote Similarity | NPC305602 |
0.5738 | Remote Similarity | NPC329011 |
0.5728 | Remote Similarity | NPC469894 |
0.5726 | Remote Similarity | NPC471310 |
0.5726 | Remote Similarity | NPC178902 |
0.5714 | Remote Similarity | NPC71140 |
0.5714 | Remote Similarity | NPC300455 |
0.5714 | Remote Similarity | NPC231705 |
0.5714 | Remote Similarity | NPC474974 |
0.5702 | Remote Similarity | NPC324569 |
0.5702 | Remote Similarity | NPC293628 |
0.5702 | Remote Similarity | NPC472788 |
0.5702 | Remote Similarity | NPC122493 |
0.5702 | Remote Similarity | NPC10781 |
0.5702 | Remote Similarity | NPC472258 |
0.5699 | Remote Similarity | NPC248705 |
0.5699 | Remote Similarity | NPC310758 |
0.5699 | Remote Similarity | NPC54368 |
0.5699 | Remote Similarity | NPC150196 |
0.5699 | Remote Similarity | NPC238023 |
0.5699 | Remote Similarity | NPC135924 |
0.5684 | Remote Similarity | NPC155172 |
0.5684 | Remote Similarity | NPC198023 |
0.5684 | Remote Similarity | NPC32312 |
0.5682 | Remote Similarity | NPC477937 |
0.568 | Remote Similarity | NPC197470 |
0.567 | Remote Similarity | NPC311343 |
0.5667 | Remote Similarity | NPC142297 |
0.5664 | Remote Similarity | NPC215351 |
0.5664 | Remote Similarity | NPC20142 |
0.566 | Remote Similarity | NPC146703 |
0.566 | Remote Similarity | NPC104070 |
0.5657 | Remote Similarity | NPC208302 |
0.5652 | Remote Similarity | NPC114327 |
0.5652 | Remote Similarity | NPC226096 |
0.5652 | Remote Similarity | NPC108606 |
0.5652 | Remote Similarity | NPC164514 |
0.5652 | Remote Similarity | NPC36357 |
0.5652 | Remote Similarity | NPC64270 |
0.5652 | Remote Similarity | NPC290515 |
0.5652 | Remote Similarity | NPC303611 |
0.5648 | Remote Similarity | NPC258046 |
0.5644 | Remote Similarity | NPC206800 |
0.5644 | Remote Similarity | NPC189371 |
0.5644 | Remote Similarity | NPC32203 |
0.5641 | Remote Similarity | NPC318154 |
0.5641 | Remote Similarity | NPC327226 |
0.5638 | Remote Similarity | NPC29680 |
0.5638 | Remote Similarity | NPC22786 |
0.5636 | Remote Similarity | NPC107135 |
0.5635 | Remote Similarity | NPC2265 |
0.5631 | Remote Similarity | NPC50192 |
0.563 | Remote Similarity | NPC67043 |
0.563 | Remote Similarity | NPC211551 |
0.5625 | Remote Similarity | NPC178527 |
0.5619 | Remote Similarity | NPC242628 |
0.5612 | Remote Similarity | NPC200936 |
0.5612 | Remote Similarity | NPC98880 |
0.5612 | Remote Similarity | NPC5324 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC317400 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD838 | Approved |
0.9775 | High Similarity | NPD837 | Approved |
0.8788 | High Similarity | NPD1406 | Approved |
0.8365 | Intermediate Similarity | NPD1747 | Approved |
0.8365 | Intermediate Similarity | NPD1746 | Approved |
0.8 | Intermediate Similarity | NPD9186 | Approved |
0.8 | Intermediate Similarity | NPD9184 | Approved |
0.7946 | Intermediate Similarity | NPD1727 | Approved |
0.78 | Intermediate Similarity | NPD234 | Approved |
0.7236 | Intermediate Similarity | NPD6076 | Approved |
0.7236 | Intermediate Similarity | NPD6075 | Approved |
0.6917 | Remote Similarity | NPD2131 | Approved |
0.6881 | Remote Similarity | NPD557 | Discovery |
0.681 | Remote Similarity | NPD2635 | Clinical (unspecified phase) |
0.6794 | Remote Similarity | NPD3126 | Approved |
0.6774 | Remote Similarity | NPD9728 | Phase 1 |
0.6759 | Remote Similarity | NPD4737 | Phase 2 |
0.6759 | Remote Similarity | NPD1796 | Phase 3 |
0.6699 | Remote Similarity | NPD1629 | Approved |
0.6699 | Remote Similarity | NPD1628 | Approved |
0.6697 | Remote Similarity | NPD1795 | Discontinued |
0.6667 | Remote Similarity | NPD9304 | Approved |
0.6667 | Remote Similarity | NPD1812 | Approved |
0.6667 | Remote Similarity | NPD4674 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD1814 | Approved |
0.6667 | Remote Similarity | NPD9538 | Approved |
0.6585 | Remote Similarity | NPD6041 | Phase 1 |
0.6583 | Remote Similarity | NPD3675 | Clinical (unspecified phase) |
0.6577 | Remote Similarity | NPD1387 | Phase 1 |
0.6571 | Remote Similarity | NPD530 | Approved |
0.6557 | Remote Similarity | NPD4651 | Clinical (unspecified phase) |
0.6557 | Remote Similarity | NPD542 | Phase 1 |
0.6552 | Remote Similarity | NPD4991 | Discontinued |
0.6538 | Remote Similarity | NPD297 | Approved |
0.6538 | Remote Similarity | NPD9 | Approved |
0.6504 | Remote Similarity | NPD804 | Clinical (unspecified phase) |
0.6486 | Remote Similarity | NPD1386 | Phase 1 |
0.6481 | Remote Similarity | NPD2507 | Clinical (unspecified phase) |
0.6476 | Remote Similarity | NPD4728 | Approved |
0.6476 | Remote Similarity | NPD2811 | Clinical (unspecified phase) |
0.6475 | Remote Similarity | NPD1104 | Approved |
0.6455 | Remote Similarity | NPD9353 | Approved |
0.6449 | Remote Similarity | NPD1080 | Approved |
0.6449 | Remote Similarity | NPD1409 | Phase 3 |
0.6446 | Remote Similarity | NPD2756 | Clinical (unspecified phase) |
0.6436 | Remote Similarity | NPD423 | Phase 3 |
0.6417 | Remote Similarity | NPD1596 | Approved |
0.6415 | Remote Similarity | NPD1007 | Discontinued |
0.6396 | Remote Similarity | NPD9248 | Phase 1 |
0.6389 | Remote Similarity | NPD1081 | Clinical (unspecified phase) |
0.6356 | Remote Similarity | NPD5662 | Approved |
0.6356 | Remote Similarity | NPD5661 | Approved |
0.6354 | Remote Similarity | NPD9590 | Approved |
0.6354 | Remote Similarity | NPD9594 | Approved |
0.6354 | Remote Similarity | NPD9591 | Approved |
0.6354 | Remote Similarity | NPD80 | Approved |
0.6354 | Remote Similarity | NPD9593 | Approved |
0.6354 | Remote Similarity | NPD9588 | Approved |
0.6354 | Remote Similarity | NPD9592 | Approved |
0.6354 | Remote Similarity | NPD9589 | Approved |
0.6333 | Remote Similarity | NPD1944 | Phase 2 |
0.6311 | Remote Similarity | NPD483 | Approved |
0.6306 | Remote Similarity | NPD784 | Discontinued |
0.6283 | Remote Similarity | NPD5655 | Clinical (unspecified phase) |
0.6273 | Remote Similarity | NPD9352 | Approved |
0.6263 | Remote Similarity | NPD295 | Approved |
0.6263 | Remote Similarity | NPD293 | Approved |
0.6263 | Remote Similarity | NPD296 | Approved |
0.625 | Remote Similarity | NPD305 | Approved |
0.625 | Remote Similarity | NPD304 | Approved |
0.6239 | Remote Similarity | NPD9188 | Approved |
0.6228 | Remote Similarity | NPD2980 | Phase 2 |
0.6214 | Remote Similarity | NPD785 | Approved |
0.621 | Remote Similarity | NPD2338 | Clinical (unspecified phase) |
0.6204 | Remote Similarity | NPD752 | Approved |
0.6204 | Remote Similarity | NPD6690 | Approved |
0.62 | Remote Similarity | NPD590 | Approved |
0.62 | Remote Similarity | NPD589 | Approved |
0.619 | Remote Similarity | NPD187 | Approved |
0.6186 | Remote Similarity | NPD505 | Clinical (unspecified phase) |
0.6182 | Remote Similarity | NPD3832 | Clinical (unspecified phase) |
0.6182 | Remote Similarity | NPD157 | Clinical (unspecified phase) |
0.6179 | Remote Similarity | NPD5569 | Clinical (unspecified phase) |
0.6167 | Remote Similarity | NPD1656 | Phase 2 |
0.6162 | Remote Similarity | NPD603 | Approved |
0.6162 | Remote Similarity | NPD4144 | Approved |
0.6162 | Remote Similarity | NPD4147 | Approved |
0.6161 | Remote Similarity | NPD1067 | Discontinued |
0.6148 | Remote Similarity | NPD4660 | Discontinued |
0.6147 | Remote Similarity | NPD197 | Approved |
0.6147 | Remote Similarity | NPD199 | Approved |
0.6146 | Remote Similarity | NPD292 | Approved |
0.6146 | Remote Similarity | NPD294 | Approved |
0.6129 | Remote Similarity | NPD4163 | Clinical (unspecified phase) |
0.6129 | Remote Similarity | NPD759 | Approved |
0.6117 | Remote Similarity | NPD831 | Approved |
0.6117 | Remote Similarity | NPD830 | Approved |
0.6116 | Remote Similarity | NPD2543 | Discontinued |
0.6116 | Remote Similarity | NPD1813 | Discontinued |
0.6106 | Remote Similarity | NPD4760 | Clinical (unspecified phase) |
0.6103 | Remote Similarity | NPD1261 | Approved |
0.61 | Remote Similarity | NPD9397 | Approved |
0.61 | Remote Similarity | NPD9393 | Approved |
0.6098 | Remote Similarity | NPD6360 | Discontinued |
0.6095 | Remote Similarity | NPD1697 | Approved |
0.6091 | Remote Similarity | NPD4814 | Discontinued |
0.609 | Remote Similarity | NPD5272 | Discontinued |
0.6087 | Remote Similarity | NPD3407 | Phase 3 |
0.6078 | Remote Similarity | NPD472 | Approved |
0.6077 | Remote Similarity | NPD767 | Phase 1 |
0.6077 | Remote Similarity | NPD4006 | Discontinued |
0.6075 | Remote Similarity | NPD9351 | Phase 3 |
0.6075 | Remote Similarity | NPD9350 | Approved |
0.6075 | Remote Similarity | NPD9108 | Approved |
0.6075 | Remote Similarity | NPD9349 | Approved |
0.6075 | Remote Similarity | NPD9348 | Approved |
0.6071 | Remote Similarity | NPD1724 | Approved |
0.6068 | Remote Similarity | NPD1824 | Discontinued |
0.6063 | Remote Similarity | NPD964 | Approved |
0.6058 | Remote Similarity | NPD1938 | Clinical (unspecified phase) |
0.6053 | Remote Similarity | NPD4119 | Approved |
0.6045 | Remote Similarity | NPD5780 | Phase 2 |
0.6045 | Remote Similarity | NPD1384 | Approved |
0.604 | Remote Similarity | NPD1053 | Approved |
0.604 | Remote Similarity | NPD1052 | Approved |
0.604 | Remote Similarity | NPD1051 | Approved |
0.6036 | Remote Similarity | NPD2895 | Discontinued |
0.6034 | Remote Similarity | NPD564 | Approved |
0.6034 | Remote Similarity | NPD563 | Approved |
0.6016 | Remote Similarity | NPD3907 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD719 | Approved |
0.6 | Remote Similarity | NPD720 | Approved |
0.6 | Remote Similarity | NPD1396 | Approved |
0.6 | Remote Similarity | NPD492 | Approved |
0.5985 | Remote Similarity | NPD5246 | Clinical (unspecified phase) |
0.5984 | Remote Similarity | NPD4478 | Clinical (unspecified phase) |
0.5982 | Remote Similarity | NPD528 | Clinical (unspecified phase) |
0.598 | Remote Similarity | NPD5372 | Approved |
0.598 | Remote Similarity | NPD260 | Discontinued |
0.598 | Remote Similarity | NPD5371 | Approved |
0.5971 | Remote Similarity | NPD5432 | Phase 2 |
0.5971 | Remote Similarity | NPD6240 | Phase 3 |
0.5965 | Remote Similarity | NPD6354 | Discontinued |
0.5962 | Remote Similarity | NPD2001 | Discontinued |
0.5954 | Remote Similarity | NPD7828 | Discontinued |
0.5941 | Remote Similarity | NPD9563 | Approved |
0.5941 | Remote Similarity | NPD9564 | Approved |
0.5941 | Remote Similarity | NPD79 | Approved |
0.5935 | Remote Similarity | NPD224 | Phase 2 |
0.5932 | Remote Similarity | NPD2243 | Clinical (unspecified phase) |
0.5929 | Remote Similarity | NPD4117 | Approved |
0.5923 | Remote Similarity | NPD572 | Clinical (unspecified phase) |
0.5922 | Remote Similarity | NPD4026 | Approved |
0.5922 | Remote Similarity | NPD3035 | Approved |
0.5922 | Remote Similarity | NPD4027 | Approved |
0.592 | Remote Similarity | NPD430 | Discontinued |
0.592 | Remote Similarity | NPD1094 | Approved |
0.5913 | Remote Similarity | NPD1540 | Approved |
0.5913 | Remote Similarity | NPD1417 | Approved |
0.5913 | Remote Similarity | NPD1419 | Approved |
0.5909 | Remote Similarity | NPD1974 | Clinical (unspecified phase) |
0.5905 | Remote Similarity | NPD3429 | Approved |
0.5905 | Remote Similarity | NPD9395 | Approved |
0.5905 | Remote Similarity | NPD3427 | Approved |
0.5897 | Remote Similarity | NPD5717 | Approved |
0.5897 | Remote Similarity | NPD1040 | Phase 2 |
0.5893 | Remote Similarity | NPD3457 | Approved |
0.5893 | Remote Similarity | NPD3458 | Approved |
0.5893 | Remote Similarity | NPD3456 | Approved |
0.5893 | Remote Similarity | NPD3093 | Approved |
0.5888 | Remote Similarity | NPD783 | Approved |
0.5888 | Remote Similarity | NPD780 | Approved |
0.5888 | Remote Similarity | NPD782 | Approved |
0.5888 | Remote Similarity | NPD4145 | Approved |
0.5888 | Remote Similarity | NPD2002 | Discontinued |
0.5888 | Remote Similarity | NPD3426 | Approved |
0.5888 | Remote Similarity | NPD3428 | Approved |
0.5888 | Remote Similarity | NPD781 | Approved |
0.5888 | Remote Similarity | NPD4146 | Approved |
0.5882 | Remote Similarity | NPD507 | Approved |
0.5882 | Remote Similarity | NPD508 | Approved |
0.5877 | Remote Similarity | NPD4007 | Approved |
0.5877 | Remote Similarity | NPD4008 | Approved |
0.5873 | Remote Similarity | NPD653 | Discontinued |
0.5865 | Remote Similarity | NPD4169 | Approved |
0.5865 | Remote Similarity | NPD4170 | Approved |
0.5865 | Remote Similarity | NPD4701 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD1542 | Approved |
0.5862 | Remote Similarity | NPD2244 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD744 | Clinical (unspecified phase) |
0.5859 | Remote Similarity | NPD3151 | Clinical (unspecified phase) |
0.5856 | Remote Similarity | NPD243 | Approved |
0.5856 | Remote Similarity | NPD8 | Approved |
0.5856 | Remote Similarity | NPD3718 | Approved |
0.5856 | Remote Similarity | NPD3719 | Approved |
0.5855 | Remote Similarity | NPD5623 | Approved |
0.5851 | Remote Similarity | NPD173 | Clinical (unspecified phase) |
0.5849 | Remote Similarity | NPD2205 | Approved |
0.5849 | Remote Similarity | NPD2208 | Approved |
0.5841 | Remote Similarity | NPD2487 | Clinical (unspecified phase) |
Molecular Weight:   | 270.10 |
ALogP:   | -0.595 |
MLogP:   | 2.12 |
XLogP:   | 3.36 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 87.14 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 2 |
# Rings:   | 1 |
# Heavy Atoms:   | 18 |